Bicycle Therapeutics PLC (NASDAQ:BCYC)

Delayed Data
As of Jun 02
 +0.96 / +3.95%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Bicycle Therapeutics PLC have a median target of 53.50, with a high estimate of 72.00 and a low estimate of 33.00. The median estimate represents a +112.64% increase from the last price of 25.16.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Buy stock in Bicycle Therapeutics PLC. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 15.35%
Growthannually -34.71%


Growthquarterly 163.84%
Growthannually 95.48%
Key to the earnings and sales forecast charts.